Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

FDA Accepts Biologics License Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment of MS
FTY720 is neuroprotective after cuprizone-induced central nervous system demyelination.
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.
Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain.
Brainstem PML lesion mimicking MS plaque in a natalizumab-treated MS patient.
Metals and Neurodegeneration.
Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients.
Efficient transdifferentiation of human adipose-derived stem cells into Schwann-like cells: A promise for treatment of demyelinating diseases.
Psychiatric symptoms in patients with multiple sclerosis.
The risk of smoking on multiple sclerosis: a meta-analysis based on 20,626 cases from case-control and cohort studies.
Expression and activation of human endogenous retroviruses of the W family in blood cells and astrocytes: implications for the pathogenesis of multiple sclerosis.
Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS.
Cognitive rehabilitation correlates with the functional connectivity of the anterior cingulate cortex in patients with multiple sclerosis.
Sarcoidosis Triggered by Interferon-Beta Treatment of Multiple Sclerosis: A Case Report and Focused Literature Review.
1st International Symposium on Gait and Balance in MS: Gait and Balance Measures in the Evaluation of People with MS.
Fatigue and Depression in Children With Demyelinating Disorders.
Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis.
Substance Name: MEDI 551
Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Are there Epstein-Barr virus seronegative patients with multiple sclerosis?
Natalizumab-induced autoimmune hepatitis in a patient with multiple sclerosis.
Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient.
Cine cerebrospinal fluid imaging in multiple sclerosis.
Association between parasite infection and immune responses in multiple sclerosis.
Extracellular O-linked β-N-acetylglucosamine: Its biology and relationship to human disease.

Pages